Product Code: ETC13365853 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Small Molecule CDMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Small Molecule CDMO Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Small Molecule CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Small Molecule CDMO Market - Industry Life Cycle |
3.4 Europe Small Molecule CDMO Market - Porter's Five Forces |
3.5 Europe Small Molecule CDMO Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Small Molecule CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Europe Small Molecule CDMO Market Revenues & Volume Share, By API Type, 2021 & 2031F |
3.8 Europe Small Molecule CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.9 Europe Small Molecule CDMO Market Revenues & Volume Share, By Facility Type, 2021 & 2031F |
3.10 Europe Small Molecule CDMO Market Revenues & Volume Share, By Regulatory Compliance, 2021 & 2031F |
4 Europe Small Molecule CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Small Molecule CDMO Market Trends |
6 Europe Small Molecule CDMO Market, 2021 - 2031 |
6.1 Europe Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Small Molecule CDMO Market, Revenues & Volume, By Drug Substance Development, 2021 - 2031 |
6.1.3 Europe Small Molecule CDMO Market, Revenues & Volume, By Drug Product Manufacturing, 2021 - 2031 |
6.1.4 Europe Small Molecule CDMO Market, Revenues & Volume, By Formulation Services, 2021 - 2031 |
6.1.5 Europe Small Molecule CDMO Market, Revenues & Volume, By Analytical Testing, 2020 - 2028 |
6.1.6 Europe Small Molecule CDMO Market, Revenues & Volume, By Packaging & Logistics, 2020 - 2028 |
6.2 Europe Small Molecule CDMO Market, Revenues & Volume, By API Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Small Molecule CDMO Market, Revenues & Volume, By Generic APIs, 2021 - 2031 |
6.2.3 Europe Small Molecule CDMO Market, Revenues & Volume, By Specialty APIs, 2021 - 2031 |
6.2.4 Europe Small Molecule CDMO Market, Revenues & Volume, By Biotech APIs, 2021 - 2031 |
6.2.5 Europe Small Molecule CDMO Market, Revenues & Volume, By Oncology Drug APIs, 2021 - 2031 |
6.2.6 Europe Small Molecule CDMO Market, Revenues & Volume, By High-Potency APIs, 2020 - 2028 |
6.3 Europe Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Small Molecule CDMO Market, Revenues & Volume, By Early-Stage Discovery, 2021 - 2031 |
6.3.3 Europe Small Molecule CDMO Market, Revenues & Volume, By Preclinical Trials, 2021 - 2031 |
6.3.4 Europe Small Molecule CDMO Market, Revenues & Volume, By Clinical Trials Phase 1, 2021 - 2031 |
6.3.5 Europe Small Molecule CDMO Market, Revenues & Volume, By Commercial Manufacturing, 2021 - 2031 |
6.3.6 Europe Small Molecule CDMO Market, Revenues & Volume, By Post- Surveillance, 2021 - 2031 |
6.4 Europe Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Small Molecule CDMO Market, Revenues & Volume, By Pilot Scale, 2021 - 2031 |
6.4.3 Europe Small Molecule CDMO Market, Revenues & Volume, By Large-Scale Production, 2021 - 2031 |
6.4.4 Europe Small Molecule CDMO Market, Revenues & Volume, By R&D Facilities, 2020 - 2028 |
6.4.5 Europe Small Molecule CDMO Market, Revenues & Volume, By Sterile Manufacturing Units, 2020 - 2028 |
6.4.6 Europe Small Molecule CDMO Market, Revenues & Volume, By Integrated Supply Chain Management, 2020 - 2028 |
6.5 Europe Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Small Molecule CDMO Market, Revenues & Volume, By US FDA & EMA Approved, 2020 - 2028 |
6.5.3 Europe Small Molecule CDMO Market, Revenues & Volume, By GMP & ISO 13485 Certified, 2020 - 2028 |
6.5.4 Europe Small Molecule CDMO Market, Revenues & Volume, By WHO GMP Standards, 2020 - 2028 |
6.5.5 Europe Small Molecule CDMO Market, Revenues & Volume, By Good Laboratory Practices, 2020 - 2028 |
6.5.6 Europe Small Molecule CDMO Market, Revenues & Volume, By Hazardous Material Handling, 2020 - 2028 |
7 Europe Small Molecule CDMO Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.2 Germany Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.3 France Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.4 Poland Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.5 Spain Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.6 Rest of Europe Small Molecule CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.3 Europe Small Molecule CDMO Market Revenues & Volume Share, By API Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) Small Molecule CDMO Market, Revenues & Volume, By API Type, 2021 - 2031 |
7.3.2 Germany Small Molecule CDMO Market, Revenues & Volume, By API Type, 2021 - 2031 |
7.3.3 France Small Molecule CDMO Market, Revenues & Volume, By API Type, 2021 - 2031 |
7.3.4 Poland Small Molecule CDMO Market, Revenues & Volume, By API Type, 2021 - 2031 |
7.3.5 Spain Small Molecule CDMO Market, Revenues & Volume, By API Type, 2021 - 2031 |
7.3.6 Rest of Europe Small Molecule CDMO Market, Revenues & Volume, By API Type, 2021 - 2031 |
7.4 Europe Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.4.1 United Kingdom (UK) Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.4.2 Germany Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.4.3 France Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.4.4 Poland Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.4.5 Spain Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.4.6 Rest of Europe Small Molecule CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.5 Europe Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
7.5.1 United Kingdom (UK) Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
7.5.2 Germany Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
7.5.3 France Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
7.5.4 Poland Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
7.5.5 Spain Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
7.5.6 Rest of Europe Small Molecule CDMO Market, Revenues & Volume, By Facility Type, 2021 - 2031 |
7.6 Europe Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2021 - 2031 |
7.6.1 United Kingdom (UK) Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2021 - 2031 |
7.6.2 Germany Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2021 - 2031 |
7.6.3 France Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2021 - 2031 |
7.6.4 Poland Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2021 - 2031 |
7.6.5 Spain Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2021 - 2031 |
7.6.6 Rest of Europe Small Molecule CDMO Market, Revenues & Volume, By Regulatory Compliance, 2021 - 2031 |
8 Europe Small Molecule CDMO Market Key Performance Indicators |
9 Europe Small Molecule CDMO Market - Export/Import By Countries Assessment |
10 Europe Small Molecule CDMO Market - Opportunity Assessment |
10.1 Europe Small Molecule CDMO Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Small Molecule CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10.3 Europe Small Molecule CDMO Market Opportunity Assessment, By API Type, 2021 & 2031F |
10.4 Europe Small Molecule CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
10.5 Europe Small Molecule CDMO Market Opportunity Assessment, By Facility Type, 2021 & 2031F |
10.6 Europe Small Molecule CDMO Market Opportunity Assessment, By Regulatory Compliance, 2021 & 2031F |
11 Europe Small Molecule CDMO Market - Competitive Landscape |
11.1 Europe Small Molecule CDMO Market Revenue Share, By Companies, 2022 |
11.2 Europe Small Molecule CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |